IL6ST rs10499563: What Your Genotype Means
The rs10499563 polymorphism is a common non-coding variant located near the interleukin-6 signal transducer (IL6ST) gene on chromosome 5. This gene encodes glycoprotein 130 (gp130), a transmembrane protein essential for mediating cytokine signals across the human immune and cardiovascular systems. Observational research links variations in this locus to subtle differences in inflammatory signaling and chronic disease predisposition, though evidence remains limited.
What each genotype means
Typical inflammatory risk profile
This genotype is considered the more common form in many populations. Research in pediatric cohorts has observed that individuals with this genotype may have a different risk profile for certain inflammatory conditions compared to those carrying the T allele, though evidence remains limited and findings are not consistent across all studies.
Carried by the majority of individuals in most studied populations, though exact frequencies vary by ancestry.
Increased inflammatory risk association
Some research has identified an association between this specific genotype and an increased risk for certain chronic inflammatory pathologies, such as ulcerative colitis in children. Because these findings are based on limited studies and may not apply to all populations or age groups, you should discuss any concerns regarding inflammatory health with your healthcare provider.
Carried by roughly 1 in 2 people of European ancestry, with a minor allele frequency of approximately 0.26.
Typical inflammatory risk profile
This genotype represents the homozygous state for the minor allele. While some studies have examined its distribution in relation to inflammatory conditions, current evidence does not suggest a significantly elevated risk compared to the general population, and findings remain limited in scope.
This is the least common genotype, found in a smaller subset of the population compared to the CC and CT genotypes.
Genomic Location and Variant Characteristics
The single nucleotide polymorphism (SNP) rs10499563 represents a single base transition (T>C) situated in a regulatory or intergenic region adjacent to the interleukin-6 signal transducer gene, also designated as IL6ST. In human genomic mapping databases such as [dbSNP](https://www.ncbi.nlm.nih.gov/snp/rs10499563), the variant is cataloged on chromosome 5. Because this genetic variant resides outside the protein-coding exons of IL6ST, it does not directly alter the amino acid sequence of the resulting protein product. Instead, non-coding single nucleotide polymorphisms in this genomic region are studied for their potential influence on gene transcription, chromatin architecture, and the expression levels of neighboring inflammatory transducers.
The Biological Role of the IL6ST Gene and gp130
The IL6ST gene provides the structural template for glycoprotein 130 (gp130), a ubiquitous trans-signaling receptor subunit shared by members of the interleukin-6 cytokine family, according to [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/3572). gp130 associates with specific alpha-receptors to form active signaling complexes that relay molecular messages into cells via the JAK-STAT and MAPK pathways. These downstream pathways are pivotal for immune cell differentiation, cellular survival, inflammatory responses, and vascular biology. Consequently, even modest regulatory fluctuations in IL6ST expression can affect how tissues respond to systemic pro-inflammatory and anti-inflammatory signaling molecules throughout life.
Current Scientific Evidence and Disease Associations
Candidate gene investigations and systematic surveys indexed in the [GWAS Catalog](https://www.ebi.ac.uk/gwas/search?query=rs10499563) have examined rs10499563 in connection with chronic systemic inflammation, cardiovascular parameters, and vascular outcomes. Studies evaluating inflammatory genes have assessed rs10499563 for statistical associations with circulating lipids, coronary artery disease, and related phenotypes as documented in [PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=rs10499563). However, the overall strength of clinical evidence connecting rs10499563 directly to primary disease outcomes remains limited. Many reported associations show modest statistical effect sizes or fail to reach strict genome-wide significance thresholds across diverse cohorts, meaning the variant acts as a modest marker rather than an independent driver of pathology.
Population Distribution and Genetic Context
Allele frequencies for rs10499563 vary noticeably across distinct geographic ancestral backgrounds documented in global population resources such as [gnomAD](https://gnomad.broadinstitute.org). In individuals of European ancestry, the minor allele frequency is approximately 0.26, indicating that more than 40 percent of individuals in this group carry at least one copy of the variant allele. Because regulatory architecture and linkage disequilibrium patterns can diverge across world populations, an association discovered in one ancestral background does not necessarily translate uniformly to individuals of East Asian, African, or Indigenous American heritage.
Interpreting Genetic Results in Clinical Context
A consumer genetic test identifying your genotype at rs10499563 cannot diagnose or predict the onset of any inflammatory or cardiovascular disorder. Complex chronic conditions develop through multifaceted interactions between dozens or hundreds of minor genetic loci, diet, physical activity, sleep quality, and environmental stressors. This genetic marker does not dictate drug regimens or replace standard medical testing. Readers interested in their cardiovascular risk or baseline inflammatory markers should discuss validated clinical tests—such as high-sensitivity C-reactive protein (hs-CRP) and lipid panels—with a licensed physician rather than relying on an isolated non-coding variant.
How common is this variant?
The minor allele frequency of rs10499563 is approximately 0.26 in populations of European ancestry, with variation observed across global ethnic groups.
Frequently asked questions
What is the function of the IL6ST gene?
The IL6ST gene produces the gp130 protein, a shared receptor subunit required for transducing signals from cytokines such as interleukin-6 and interleukin-11. These cytokine signals coordinate immune cell maturation, tissue repair, and systemic inflammatory reactions throughout the body.
Does having the rs10499563 variant mean I will get a heart or inflammatory disease?
No. rs10499563 is a common genetic marker with limited scientific evidence linking it to modest statistical variations in risk across broad population cohorts. It does not cause disease on its own, and lifestyle factors alongside overall medical history play a far greater role in chronic disease risk.
Can rs10499563 help decide my response to anti-inflammatory medications?
Currently, there are no clinically validated pharmacogenomic guidelines that recommend adjusting medications based on rs10499563 genotype. Any changes to prescription medications or anti-inflammatory therapies should always be discussed directly with a qualified healthcare provider or pharmacist.
Why is the evidence for rs10499563 categorized as limited?
Scientific evidence is considered limited because most associations stem from candidate-gene surveys or non-replicated observational cohorts rather than large-scale, genome-wide studies with functional biological validation. Many published findings also show slight effect sizes that may not generalize across different ancestral backgrounds.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10499563?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29